Search Results - "Tibbo, Philip G"

Refine Results
  1. 1

    Long-acting injectable antipsychotic (LAI) prescribing trends during COVID-19 restrictions in Canada: a retrospective observational study by McKee, Kyle A, Crocker, Candice E, Tibbo, Philip G

    Published in BMC psychiatry (20-12-2021)
    “…The COVID-19 pandemic has had significant impacts on how mental health services are delivered to patients throughout Canada. The reduction of in-person…”
    Get full text
    Journal Article
  2. 2

    Mental health adverse events with cannabis use diagnosed in the Emergency Department: what are we finding now and are our findings accurate? by Crocker, Candice E, Emsley, Jason, Tibbo, Philip G

    Published in Frontiers in psychiatry (25-05-2023)
    “…We have previously reviewed the types and numbers of cannabis-associated adverse events that have mental health presentations that are encountered in the…”
    Get full text
    Journal Article
  3. 3

    Do Anxiety Symptoms Mediate the Association Between Cannabis Use Frequency and Psychotic-Like Experiences in Emerging Adult Undergraduates? by Bernusky, Haley C. R., Tibbo, Philip G., Conrod, Patricia J., Yunus, Fakir Md, Keough, Matthew T., Thompson, Kara D., Krank, Marvin D., Hadwin, Allyson F., Stewart, Sherry H.

    Published in Canadian journal of psychiatry (01-11-2023)
    “…Objective Cannabis is commonly used by Canadian emerging adults (ages 18–25 years), many of whom attend post-secondary institutions. Frequent cannabis use is…”
    Get full text
    Journal Article
  4. 4

    When Cannabis Use Goes Wrong: Mental Health Side Effects of Cannabis Use That Present to Emergency Services by Crocker, Candice E, Carter, Alix J E, Emsley, Jason G, Magee, Kirk, Atkinson, Paul, Tibbo, Philip G

    Published in Frontiers in psychiatry (15-02-2021)
    “…Cannabis use is a modifiable risk factor for the development and exacerbation of mental illness. The strongest evidence of risk is for the development of a…”
    Get full text
    Journal Article
  5. 5

    Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia by Crocker, Candice E, Tibbo, Philip G

    Published in Frontiers in pharmacology (18-10-2018)
    “…Despite development of comprehensive approaches to treat schizophrenia and other psychotic disorders and improve outcomes, there remains a proportion…”
    Get full text
    Journal Article
  6. 6

    Mismatch negativity-indexed auditory change detection of speech sounds in early and chronic schizophrenia by Fisher, Derek J., Rudolph, Erica D., Ells, Emma M.L., Knott, Verner J., Labelle, Alain, Tibbo, Philip G.

    Published in Psychiatry research. Neuroimaging (30-05-2019)
    “…•Auditory mismatch negativity (MMN) assessed with phonetic (vowel) stimuli.•Early schizophrenia patients did not exhibit a reduced MMN (vs. controls).•Chronic…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Finding the missing-stimulus mismatch negativity (MMN) in early psychosis: Altered MMN to violations of an auditory gestalt by Rudolph, Erica D, Ells, Emma M.L, Campbell, Debra J, Abriel, Shelagh C, Tibbo, Philip G, Salisbury, Dean F, Fisher, Derek J

    Published in Schizophrenia research (01-08-2015)
    “…Abstract The mismatch negativity (MMN) is an EEG-derived event-related potential (ERP) elicited by any violation of a predicted auditory ‘rule’, regardless of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Corrigendum: Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia by Crocker, Candice E, Tibbo, Philip G

    Published in Frontiers in pharmacology (04-12-2018)
    “…[This corrects the article DOI: 10.3389/fphar.2018.01172.]…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Genetic factors contribute to medication-induced QT prolongation: A review by Toba-Oluboka, Temi, Tibbo, Philip G., Dempster, Kara, Alda, Martin

    Published in Psychiatry research (01-11-2022)
    “…•Genetics contribute considerable risk to medication-induced QT prolongation.•The paucity of studies highlights the importance for further research on this…”
    Get full text
    Journal Article
  13. 13

    Heterogeneity in assessing the risk of developing a psychotic disorder given a previous subclinical psychotic-like experience in children and adolescents: A systematic review and meta-analysis by Burton, Isaiah J, Tibbo, Philip G, Ponto, Nicole, Crocker, Candice E

    Published in Psychiatry research (01-12-2024)
    “…•Child and adolescent PLEs increase the risk of psychosis onset by young adulthood.•A third of psychotic disorder diagnoses are attributed to child or…”
    Get full text
    Journal Article
  14. 14

    The interaction of gender and cannabis in early phase psychosis by Crocker, Candice E, Tibbo, Philip G

    Published in Schizophrenia research (01-04-2018)
    “…Abstract Cannabis is the third most common recreational drug used world-wide after tobacco and alcohol. Globally, cannabis legalization is becoming more…”
    Get full text
    Journal Article
  15. 15

    The role of referral pathway to early intervention services for psychosis on 2-year inpatient and emergency service use by Senger, Brannon, Pencer, Alissa, Crocker, Candice E., Simon, Patryk, Taylor, Bryanne, Tibbo, Philip G.

    Published in Journal of psychiatric research (01-04-2024)
    “…This study examined the relationship between terminal referral source and subsequent urgent health service use in a Canadian early intervention service (EIS)…”
    Get full text
    Journal Article
  16. 16

    Is performance on probed serial recall tasks in schizophrenia related to duration of Attentional Blink? by McAllindon, David P, Tibbo, Philip G, Eskes, Gail A

    Published in Schizophrenia research. Cognition (01-03-2017)
    “…Abstract Schizophrenia is associated with a deficit in working memory, with the degree of working memory impairment related to the level of social and…”
    Get full text
    Journal Article
  17. 17

    White matter changes in early phase schizophrenia and cannabis use: An update and systematic review of diffusion tensor imaging studies by Cookey, Jacob, Bernier, Denise, Tibbo, Philip G

    Published in Schizophrenia research (01-07-2014)
    “…Abstract Objectives The impact of cannabis use on the brain tissue is still unclear, both in the healthy developing brain and in people with schizophrenia. The…”
    Get full text
    Journal Article
  18. 18

    Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis by Bahji, Anees, Meyyappan, Arthi Chinna, Hawken, Emily R, Tibbo, Philip G.

    Published in The International journal of drug policy (01-11-2021)
    “…This study aimed to determine the efficacy and acceptability of pharmacotherapies for cannabis use disorder (CUD). We conducted a systematic review and…”
    Get full text
    Journal Article
  19. 19

    A cross-sectional study of the relationship between frequency of cannabis use and psychiatric symptoms among people seeking mental health and addiction services in Nova Scotia (2019–21) by Yang, Lu, Tibbo, Philip G., Stewart, Sherry H., Simon, Patryk, Bullerwell, Michele, Wang, JianLi

    Published in Journal of psychiatric research (01-05-2024)
    “…Cannabis use may be a modifiable risk factor for mental health problems; however, the role of cannabis use frequency in population seeking mental health and…”
    Get full text
    Journal Article
  20. 20

    Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data by Merritt, Kate, McGuire, Philip K, Egerton, Alice, Aleman, André, Block, Wolfgang, Bloemen, Oswald J N, Borgan, Faith, Bustillo, Juan R, Capizzano, Aristides A, Coughlin, Jennifer Marie, De la Fuente-Sandoval, Camilo, Demjaha, Arsime, Dempster, Kara, Do, Kim Q, Du, Fei, Falkai, Peter, Galinska-Skok, Beata, Gallinat, Jurgen, Gasparovic, Charles, Ginestet, Cedric E, Goto, Naoki, Graff-Guerrero, Ariel, Ho, Beng Choon, Howes, Oliver D, Jauhar, Sameer, Jeon, Peter, Kato, Tadafumi, Kaufmann, Charles A, Kegeles, Lawrence S, Keshavan, Matcheri, Kim, Sang-Young, Kunugi, Hiroshi, Lauriello, John, Liemburg, Edith Jantine, Mcilwain, Meghan E, Modinos, Gemma, Mouchlianitis, Elias D, Nakamura, Jun, Nenadic, Igor, Öngür, Dost, Ota, Miho, Palaniyappan, Lena, Pantelis, Christos, Plitman, Eric, Posporelis, Sotirios, Purdon, Scot E, Reichenbach, Jürgen R, Renshaw, Perry F, Russell, Bruce R, Sawa, Akira, Schaefer, Martin, Shungu, Dikoma C, Smesny, Stefan, Stanley, Jeffrey A, Stone, James M, Szulc, Agata, Taylor, Reggie, Thakkar, Katy, Théberge, Jean, Tibbo, Philip G, van Amelsvoort, Therese, Walecki, Jerzy, Williamson, Peter C, Wood, Stephen James, Xin, Lijing, Yamasue, Hidenori

    Published in JAMA psychiatry (Chicago, Ill.) (01-06-2021)
    “…Proton magnetic resonance spectroscopy (1H-MRS) studies indicate that altered brain glutamatergic function may be associated with the pathophysiology of…”
    Get more information
    Journal Article